002294 信立泰
已收盘 11-19 15:00:00
资讯
新帖
简况
信立泰(002294)11月17日主力资金净卖出1.07亿元
证券之星 · 11-18 09:17
信立泰(002294)11月17日主力资金净卖出1.07亿元
11月17日信立泰跌9.65%,富国中证沪港深创新药产业ETF发起式联接A基金重仓该股
证券之星 · 11-17 16:48
11月17日信立泰跌9.65%,富国中证沪港深创新药产业ETF发起式联接A基金重仓该股
信立泰最新公告:复立坦、信立汀等药品继续纳入国家医保目录
证券之星 · 11-15
信立泰最新公告:复立坦、信立汀等药品继续纳入国家医保目录
信立泰:关于控股股东部分股份解除质押的公告
同花顺 · 11-11
信立泰:关于控股股东部分股份解除质押的公告
信立泰(002294)11月10日主力资金净卖出3918.97万元
证券之星 · 11-11
信立泰(002294)11月10日主力资金净卖出3918.97万元
股市必读:信立泰新发布《关于回购公司股份的进展公告》
证券之星 · 11-04
股市必读:信立泰新发布《关于回购公司股份的进展公告》
股市必读:信立泰新发布《关于回购公司股份的进展公告》
证券之星 · 11-02
股市必读:信立泰新发布《关于回购公司股份的进展公告》
研报掘金|东吴证券:维持信立泰“买入”评级,公司慢病管理平台价值将持续兑现
格隆汇 · 10-30
研报掘金|东吴证券:维持信立泰“买入”评级,公司慢病管理平台价值将持续兑现
股市必读:信立泰新发布《关于回购公司股份的进展公告》
证券之星 · 10-30
股市必读:信立泰新发布《关于回购公司股份的进展公告》
信立泰(002294)披露2026年三季度报告,10月27日股价下跌0.69%
证券之星 · 10-27
信立泰(002294)披露2026年三季度报告,10月27日股价下跌0.69%
信立泰(002294)9月30日股东户数8.32万户,较上期减少2.82%
证券之星 · 10-26
信立泰(002294)9月30日股东户数8.32万户,较上期减少2.82%
图解信立泰三季报:第三季度单季净利润同比增长19.24%
证券之星 · 10-26
图解信立泰三季报:第三季度单季净利润同比增长19.24%
信立泰(002294.SZ)发布前三季度业绩,归母净利润6.44亿元,同比增长10.93%
智通财经 · 10-26
信立泰(002294.SZ)发布前三季度业绩,归母净利润6.44亿元,同比增长10.93%
股市必读:信立泰新发布《关于JK06境内临床试验申请获得受理的公告》
证券之星 · 10-26
股市必读:信立泰新发布《关于JK06境内临床试验申请获得受理的公告》
信立泰最新公告:JK06境内临床试验申请获受理
证券之星 · 10-23
信立泰最新公告:JK06境内临床试验申请获受理
10月22日信立泰跌5.20%,光大健康优加混合A基金重仓该股
证券之星 · 10-22
10月22日信立泰跌5.20%,光大健康优加混合A基金重仓该股
信立泰(002294)10月19日主力资金净买入7433.11万元
证券之星 · 10-20
信立泰(002294)10月19日主力资金净买入7433.11万元
信立泰(002294)10月15日主力资金净买入396.34万元
证券之星 · 10-16
信立泰(002294)10月15日主力资金净买入396.34万元
股市必读:信立泰新发布《关于回购公司股份的进展公告》
证券之星 · 10-12
股市必读:信立泰新发布《关于回购公司股份的进展公告》
信立泰(002294)披露回购公司股份进展公告,10月9日股价上涨2.59%
证券之星 · 10-09
信立泰(002294)披露回购公司股份进展公告,10月9日股价上涨2.59%
暂无数据
公司概况
公司名称:
深圳信立泰药业股份有限公司
所属行业:
医药制造业
上市日期:
2009-09-10
主营业务:
深圳信立泰药业股份有限公司的主营业务是药品、医疗器械产品的研发、生产、销售,以及专利授权许可。公司的主要产品是心脑血管、肾脏、代谢类药物及医疗器械、骨科药物、头孢类抗生素及原料。
发行价格:
41.98
{"stockData":{"symbol":"002294","market":"SZ","secType":"STK","nameCN":"信立泰","latestPrice":26.35,"timestamp":1795071828000,"preClose":26.8,"halted":0,"volume":13695230,"delay":0,"changeRate":-0.0168,"floatShares":1115000000,"shares":1115000000,"eps":0.6414,"marketStatus":"已收盘","change":-0.45,"latestTime":"11-19 15:00:00","open":26.71,"high":26.92,"low":25.86,"amount":358000000,"amplitude":0.0396,"askPrice":26.35,"askSize":29,"bidPrice":26.3,"bidSize":1,"shortable":0,"etf":0,"ttmEps":0.6414,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795138200000},"marketStatusCode":5,"adr":0,"adjPreClose":26.8,"symbolType":"stock","openAndCloseTimeList":[[1795051800000,1795059000000],[1795064400000,1795071600000]],"highLimit":29.48,"lowLimit":24.12,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1114816535,"isCdr":false,"pbRate":3.45,"roa":"--","peRate":41.082008,"roe":"7.23%","epsLYR":0.58,"committee":-0.621622,"marketValue":29375000000,"turnoverRate":0.0123,"status":1,"floatMarketCap":29369000000},"requestUrl":"/m/hq/s/002294/tweets","defaultTab":"tweets","newsList":[{"id":"2684584419","title":"信立泰(002294)11月17日主力资金净卖出1.07亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2684584419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684584419?lang=zh_cn&edition=full","pubTime":"2026-11-18 09:17","pubTimestamp":1794964633,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月17日收盘,信立泰报收于26.67元,下跌9.65%,换手率2.1%,成交量23.43万手,成交额6.51亿元。近5日资金流向一览见下表:信立泰融资融券信息显示,融资方面,当日融资买入6828.0万元,融资偿还7988.34万元,融资净偿还1160.34万元。信立泰主营业务:药品、医疗器械产品的研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111800010739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0183","BK0187","BK0239","002294","BK0196","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684185608","title":"11月17日信立泰跌9.65%,富国中证沪港深创新药产业ETF发起式联接A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2684185608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684185608?lang=zh_cn&edition=full","pubTime":"2026-11-17 16:48","pubTimestamp":1794905334,"startTime":"0","endTime":"0","summary":"根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为富国基金的富国中证沪港深创新药产业ETF发起式联接A。富国中证沪港深创新药产业ETF发起式联接A目前规模为1.17亿元,最新净值1.1341,较上一交易日下跌1.55%,近一年下跌3.93%。富国中证沪港深创新药产业ETF发起式联接A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111700029942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK1574","BK0196","BK0187","BK0239","BK1161","06978","BK0183","002294","159992","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683073655","title":"信立泰最新公告:复立坦、信立汀等药品继续纳入国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2683073655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683073655?lang=zh_cn&edition=full","pubTime":"2026-11-15 16:19","pubTimestamp":1794730757,"startTime":"0","endTime":"0","summary":"信立泰(002294.SZ)公告称,公司药品复立坦(阿利沙坦酯氨氯地平片)、信立汀(苯甲酸福格列汀片)续约成功,恩那罗(恩那度司他片)新增适应症谈判成功并保留在医保目录内。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111500004030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0183","002294","BK0188","BK0196","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682304320","title":"信立泰:关于控股股东部分股份解除质押的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2682304320","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682304320?lang=zh_cn&edition=full","pubTime":"2026-11-11 20:42","pubTimestamp":1794400920,"startTime":"0","endTime":"0","summary":" 证券日报网讯 11月11日,信立泰发布公告称,公司于近日接到公司控股股东信立泰药业有限公司的通知,获悉其将所持有的本公司部分股份解除质押。本次解除质押16 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261111/c681722049.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261111/c681722049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0239","BK0187","002294","BK0196","BK0188","BK0028","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682332349","title":"信立泰(002294)11月10日主力资金净卖出3918.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682332349","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682332349?lang=zh_cn&edition=full","pubTime":"2026-11-11 09:22","pubTimestamp":1794360162,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月10日收盘,信立泰报收于30.74元,下跌0.77%,换手率0.9%,成交量10.07万手,成交额3.09亿元。近5日资金流向一览见下表:信立泰融资融券信息显示,融资方面,当日融资买入2260.59万元,融资偿还2051.35万元,融资净买入209.24万元。信立泰主营业务:药品、医疗器械产品的研发、生产、销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100014574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0187","BK0196","BK0239","002294","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680775235","title":"股市必读:信立泰新发布《关于回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680775235","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680775235?lang=zh_cn&edition=full","pubTime":"2026-11-04 01:14","pubTimestamp":1793726091,"startTime":"0","endTime":"0","summary":"公司公告汇总:截至2026年10月31日,信立泰已回购股份8,577,140股,占总股本0.77%,成交总金额27,395.79万元。公司公告汇总关于回购公司股份的进展公告深圳信立泰药业股份有限公司于2026年5月29日召开第六届董事会第十九次会议,审议通过回购公司股份的议案,拟以自有资金及自筹资金回购公司A股股份,回购总金额不低于30,000万元且不超过50,000万元,回购价格不超过45元/股,实施期限为董事会审议通过之日起不超过12个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400002419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0187","BK0183","BK0188","BK0028","002294","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680207105","title":"股市必读:信立泰新发布《关于回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680207105","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680207105?lang=zh_cn&edition=full","pubTime":"2026-11-02 03:06","pubTimestamp":1793559975,"startTime":"0","endTime":"0","summary":"公司公告汇总:截至10月29日,信立泰已回购股份8,577,140股,占总股本0.77%,成交总金额27,395.79万元。公司公告汇总关于回购公司股份的进展公告深圳信立泰药业股份有限公司于2026年5月29日召开第六届董事会第十九次会议,审议通过回购公司股份的议案,拟以自有资金及自筹资金回购公司A股股份,回购金额不低于30,000万元且不超过50,000万元,回购价格不超过45元/股,实施期限为董事会审议通过之日起不超过12个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200000783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0187","BK0188","BK0028","BK0196","002294","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679296560","title":"研报掘金|东吴证券:维持信立泰“买入”评级,公司慢病管理平台价值将持续兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2679296560","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679296560?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:18","pubTimestamp":1793351898,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0188","BK0183","002294","BK0276","BK0028","BK0196","601555","BK0009","BK0239","BK0187","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679375932","title":"股市必读:信立泰新发布《关于回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2679375932","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679375932?lang=zh_cn&edition=full","pubTime":"2026-10-30 05:48","pubTimestamp":1793310515,"startTime":"0","endTime":"0","summary":"公司公告汇总:截至2026年10月29日,信立泰已回购股份8,577,140股,占总股本0.77%,成交总金额27,395.79万元。公司公告汇总关于回购公司股份的进展公告深圳信立泰药业股份有限公司于2026年5月29日召开第六届董事会第十九次会议,审议通过回购公司股份的议案,拟以自有资金及自筹资金回购公司A股股份,回购金额不低于30,000万元且不超过50,000万元,回购价格不超过45元/股,实施期限为董事会审议通过之日起不超过12个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000008993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","002294","BK0188","BK0196","BK0183","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678791691","title":"信立泰(002294)披露2026年三季度报告,10月27日股价下跌0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678791691","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678791691?lang=zh_cn&edition=full","pubTime":"2026-10-27 19:10","pubTimestamp":1793099443,"startTime":"0","endTime":"0","summary":"截至2026年10月27日收盘,信立泰报收于30.43元,较前一交易日下跌0.69%,最新总市值为339.24亿元。该股当日开盘31.1元,最高31.35元,最低30.3元,成交额达2.89亿元,换手率为0.84%。公司于2026年10月27日披露《2026年三季度报告》。报告显示,本报告期营业收入1,263,642,115.72元,同比增长13.81%;归属于上市公司股东的净利润257,108,810.98元,同比增长19.24%。年初至报告期末营业收入3,742,777,875.90元,同比增长15.47%;归属于上市公司股东的净利润644,200,537.73元,同比增长10.93%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700036520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0187","002294","BK0196","BK0188","BK0028","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678169733","title":"信立泰(002294)9月30日股东户数8.32万户,较上期减少2.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678169733","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678169733?lang=zh_cn&edition=full","pubTime":"2026-10-26 17:55","pubTimestamp":1793008558,"startTime":"0","endTime":"0","summary":"证券之星消息,近日信立泰披露,截至2026年9月30日公司股东户数为8.32万户,较9月10日减少2417.0户,减幅为2.82%。在化学制药行业个股中,信立泰股东户数高于行业平均水平,截至9月30日,化学制药行业平均股东户数为3.67万户。从股价来看,2026年9月10日至2026年9月30日,信立泰区间跌幅为1.22%,在此期间股东户数减少2417.0户,减幅为2.82%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600024220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002294","BK0196","BK0188","BK0187","BK0183","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678169804","title":"图解信立泰三季报:第三季度单季净利润同比增长19.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678169804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678169804?lang=zh_cn&edition=full","pubTime":"2026-10-26 17:40","pubTimestamp":1793007657,"startTime":"0","endTime":"0","summary":"证券之星消息,信立泰2026年三季报显示,前三季度公司主营收入37.43亿元,同比上升15.47%;归母净利润6.44亿元,同比上升10.93%;扣非净利润6.25亿元,同比上升10.21%;其中2026年第三季度,公司单季度主营收入12.64亿元,同比上升13.81%;单季度归母净利润2.57亿元,同比上升19.24%;单季度扣非净利润2.24亿元,同比上升1.68%;负债率21.75%,投资收益4736.95万元,财务费用1482.21万元,毛利率74.19%。财报数据概要请见下图:本文数据来源于信立泰2026年三季报,仅供参考不构成投资建议。相关 ETF","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600023614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002294"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678150209","title":"信立泰(002294.SZ)发布前三季度业绩,归母净利润6.44亿元,同比增长10.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678150209","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678150209?lang=zh_cn&edition=full","pubTime":"2026-10-26 16:04","pubTimestamp":1793001868,"startTime":"0","endTime":"0","summary":"智通财经APP讯,信立泰(002294.SZ)发布2026年第三季度报告,公司前三季度实现营业收入37.43亿元,同比增长15.47%;归属于上市公司股东的净利润6.44亿元,同比增长10.93%;归属于上市公司股东的扣除非经常性损益的净利润6.25亿元,同比增长10.21%;基本每股收益0.58元。2026年前三季度,创新产品商业化梯队不断丰富并逐步放量,推动营业收入和净利润的持续增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512332.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002294"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678713635","title":"股市必读:信立泰新发布《关于JK06境内临床试验申请获得受理的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678713635","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678713635?lang=zh_cn&edition=full","pubTime":"2026-10-26 01:58","pubTimestamp":1792951092,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘,信立泰报收于30.79元,上涨2.98%,换手率1.3%,成交量14.44万手,成交额4.35亿元。公司公告汇总:信立泰创新药JK06注射液境内临床试验申请获国家药监局受理,拟用于肺癌和乳腺癌等实体瘤治疗。JK06为一种选择性靶向5T4的双表位抗体药物偶联物,拟用于肺癌和乳腺癌等实体瘤治疗。本次申请受理后尚需取得临床试验默示许可,并按相关规定开展临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600000572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0239","002294","BK0183","BK0196","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677926090","title":"信立泰最新公告:JK06境内临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2677926090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677926090?lang=zh_cn&edition=full","pubTime":"2026-10-23 19:10","pubTimestamp":1792753856,"startTime":"0","endTime":"0","summary":"信立泰(002294.SZ)公告称,公司收到国家药品监督管理局出具的受理通知书,创新药“JK06注射液”临床试验申请获得受理。JK06为选择性靶向5T4的双表位抗体药物偶联物,适应证拟为包括肺癌和乳腺癌在内的实体瘤。该产品目前正在欧洲部分国家开展I/II期临床试验。本次境内临床申请获受理后,尚需获得临床试验默示许可,存在不确定性,短期内对公司业绩不会产生实际影响。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300037993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0239","BK0183","BK0188","002294","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677958494","title":"10月22日信立泰跌5.20%,光大健康优加混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677958494","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677958494?lang=zh_cn&edition=full","pubTime":"2026-10-22 16:44","pubTimestamp":1792658684,"startTime":"0","endTime":"0","summary":"证券之星消息,10月22日信立泰跌5.20%,收盘报29.9元,换手率1.4%,成交量15.58万手,成交额4.74亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为光大保德信基金的光大健康优加混合A。光大健康优加混合A目前规模为6.23亿元,最新净值0.7935,较上一交易日上涨0.1%,近一年下跌10.42%。光大健康优加混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200028655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","002294","BK0239","BK0188","BK0187","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676963019","title":"信立泰(002294)10月19日主力资金净买入7433.11万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676963019","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676963019?lang=zh_cn&edition=full","pubTime":"2026-10-20 09:09","pubTimestamp":1792458581,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月19日收盘,信立泰报收于31.78元,上涨3.05%,换手率1.93%,成交量21.55万手,成交额6.73亿元。近5日资金流向一览见下表:信立泰融资融券信息显示,融资方面,当日融资买入3053.09万元,融资偿还4588.52万元,融资净偿还1535.43万元。融券方面,融券卖出500.0股,融券偿还100.0股,融券余量17.34万股,融券余额551.07万元。信立泰主营业务:药品、医疗器械产品的研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000006269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0183","BK0187","BK0239","002294","BK0196","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675517845","title":"信立泰(002294)10月15日主力资金净买入396.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675517845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675517845?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:06","pubTimestamp":1792112769,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月15日收盘,信立泰报收于30.58元,上涨0.49%,换手率1.68%,成交量18.68万手,成交额5.76亿元。近5日资金流向一览见下表:信立泰融资融券信息显示,融资方面,当日融资买入2732.95万元,融资偿还3252.49万元,融资净偿还519.54万元。融券方面,融券卖出2.2万股,融券偿还100.0股,融券余量17.34万股,融券余额530.26万元。信立泰主营业务:药品、医疗器械产品的研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600008707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","002294","BK0188","BK0196","BK0239","BK0187","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674784526","title":"股市必读:信立泰新发布《关于回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674784526","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674784526?lang=zh_cn&edition=full","pubTime":"2026-10-12 02:47","pubTimestamp":1791744429,"startTime":"0","endTime":"0","summary":"公司公告汇总:截至2026年9月30日,信立泰已回购股份8,319,640股,占总股本0.75%,成交总金额26,617.19万元,回购进展符合方案规定。公司公告汇总关于回购公司股份的进展公告深圳信立泰药业股份有限公司于2026年5月29日召开董事会,审议通过回购公司股份的议案,拟以自有资金及自筹资金回购A股股份,资金总额不低于30,000万元且不超过50,000万元,回购价格不超过45元/股,回购期限为董事会审议通过之日起不超过12个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","002294","BK0188","BK0183","BK0028","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674307298","title":"信立泰(002294)披露回购公司股份进展公告,10月9日股价上涨2.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674307298","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674307298?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:43","pubTimestamp":1791539022,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘,信立泰报收于30.93元,较前一交易日上涨2.59%,最新总市值为344.81亿元。该股当日开盘30.15元,最高31.15元,最低29.68元,成交额达3.21亿元,换手率为0.95%。公司于2026年10月9日披露《关于回购公司股份的进展公告》。本次回购股份将用于实施股权激励或员工持股计划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900027995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0183","BK0028","BK0187","BK0188","BK0196","002294"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795126346640,"stockEarnings":[{"period":"1week","weight":-0.1152},{"period":"1month","weight":-0.1632},{"period":"3month","weight":-0.1937},{"period":"6month","weight":-0.2426},{"period":"1year","weight":-0.5567},{"period":"ytd","weight":-0.4597}],"compareEarnings":[{"period":"1week","weight":-0.0214},{"period":"1month","weight":-0.0422},{"period":"3month","weight":-0.0839},{"period":"6month","weight":-0.1301},{"period":"1year","weight":-0.0935},{"period":"ytd","weight":-0.0986}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳信立泰药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"83193人(较上一季度减少2.82%)","perCapita":"13397股","listingDate":"2009-09-10","address":"广东省深圳市福田区福保街道福保社区红柳道2号289数字半岛4层A区","registeredCapital":"111481万元","survey":" 深圳信立泰药业股份有限公司的主营业务是药品、医疗器械产品的研发、生产、销售,以及专利授权许可。公司的主要产品是心脑血管、肾脏、代谢类药物及医疗器械、骨科药物、头孢类抗生素及原料。","listedPrice":41.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"信立泰(002294)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供信立泰(002294)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"信立泰,002294,信立泰股票,信立泰股票老虎,信立泰股票老虎国际,信立泰行情,信立泰股票行情,信立泰股价,信立泰股市,信立泰股票价格,信立泰股票交易,信立泰股票购买,信立泰股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"信立泰(002294)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供信立泰(002294)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}